Compare PayPal Holdings, Inc. (PYPL) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PayPal Holdings, Inc. vs Repligen Corporation Common Stock — how do they compare? PayPal Holdings, Inc. trades at $56.17 (market cap $48.05B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: PayPal Holdings, Inc. is far larger — about 4.3× Repligen Corporation Common Stock's market cap, and PayPal Holdings, Inc. pays a 1% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold PayPal Holdings, Inc. for 106 Days and Repligen Corporation Common Stock for 0 Days on average.
| PYPL | RGEN | |
|---|---|---|
Market Cap | $48.05B | $11.14B |
Volume | 7,905,570 | 1,259,263 |
Sector | Financials | Health |
52-Week High | $73.01 | $194.57 |
52-Week Low | $39.08 | $102.87 |
Typical Hold Time | 106 Days | 0 Days |
Enterprise Value | $50.20B | $11.02B |
Dividend Yield | 1% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PayPal (PYPL) trades at $56.17, up 0.21% today, with a bullish technical signal from moving averages and oscillators. The stock shows strong fundamentals with a low P/E of 10.62 and robust profitability, including a 14.36% net income margin. Recent earnings beat expectations in Q1 and Q2 2026, and a new partnership with Meta announced on September 22, 2026, has boosted investor optimism. Cash flow remains healthy, with net cash flow of $1.53 billion in 2025.
The outlook for PayPal is cautiously optimistic, supported by valuation discounts and strategic initiatives under new CEO Enrique Lores. However, risks include competitive pressures in digital payments and slowing growth in branded checkout. Analyst consensus is a 'Hold' with a $56.41 price target, reflecting mixed sentiment amid turnaround efforts.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
